Association between hearing impairment and cardiometabolic multimorbidity among middle-aged and older adults in China

Xiao-Duo Zhang1,2,3, Qia-Chun Zhang4, Bin Deng4

  • 1Guangxi University of Chinese Medicine, Nanning, Guangxi, China. 308996191@qq.com.

Scientific Reports
|April 3, 2026
PubMed

Insights

Hearing impairment (HI) significantly increases the risk of cardiometabolic multimorbidity (CMM) in older adults. Even mild HI raises CMM risk by 32%, with severe HI posing a 54% greater risk.

Area of Science:

  • Gerontology
  • Cardiology
  • Otolaryngology

Background:

  • Cardiometabolic multimorbidity (CMM) presents a significant health challenge in aging populations.
  • Hearing impairment (HI) is a prevalent condition among middle-aged and older adults.
  • The relationship between HI and CMM risk requires further investigation.

Purpose of the Study:

  • To examine the association between hearing impairment (HI) and the risk of developing cardiometabolic multimorbidity (CMM).
  • To provide evidence for early warning and screening of high-risk CMM populations.

Main Methods:

  • Analysis of data from 9,035 participants aged 45+ in the China Health and Retirement Longitudinal Study (2011-2018).
  • Utilized multivariable Cox proportional hazards regression, Kaplan-Meier survival curves, and subgroup analyses.
  • Median follow-up duration was 7 years, documenting 382 incident CMM cases.

Main Results:

  • Mild HI was associated with a 32% increased risk of CMM (HR=1.32, 95% CI: 1.06-1.68).
  • Severe HI was associated with a 54% increased risk of CMM (HR=1.54, 95% CI: 1.14-2.07).
  • Subgroup analyses indicated higher risks for males with severe HI (HR=1.72), females with severe HI (HR=1.55), and individuals aged ≥60 with severe HI (HR=1.70).

Conclusions:

  • Hearing impairment is associated with an elevated risk of cardiometabolic multimorbidity in middle-aged and older adults.
  • The association between HI and CMM risk is more pronounced in males and individuals aged 60 and older.
  • Findings support the consideration of HI screening for early detection of CMM risk.